The antivitamin B 6  effect of penicillamine: clinical and immunological implications.
D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000276:immunology; D004336:Drug Antagonism; D004347:Drug Interactions; D006801:Humans; D007165:Immunosuppression Therapy; D007737:Kynurenine / Q000652:urine; D010396:Penicillamine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D011233:Precipitin Tests; D011736:Pyridoxine / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D012217:Rheumatoid Factor / Q000032:analysis; D014364:Tryptophan / Q000652:urine; D026681:Vitamin B 6 Deficiency / Q000139:chemically induced / Q000276:immunology; D014977:Xanthurenates / Q000652:urine
D014977:Xanthurenates; D007737:Kynurenine; D014364:Tryptophan; D012217:Rheumatoid Factor; D010396:Penicillamine; D011736:Pyridoxine